One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Innovative therapeutic targets in cardio-oncology and a Great Debate in heart failureÂ
Filippo Crea
doi : 10.1093/eurheartj/ehae397
Volume 45, Issue 25, 1 July 2024
Management of heart failure in Mexico: challenges and opportunitiesÂ
Ten years of direct oral anticoagulants: lessons learned and challenges aheadÂ
The obesity syndemic in the European community: towards a systems thinking approach for preventive policies
Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention—ready for prime time?
Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction
The year in cardiovascular medicine 2023: the top 10 papers in cardio-oncology
Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study
Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions
Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters
Rescue of cardiac dysfunction during chemotherapy in acute myeloid leukaemia by blocking IL-1α
Percutaneous stellate ganglion block for electrical storm treatment: the new rising STAR?
Percutaneous stellate ganglion block and catheter ablation: not enemies but allies in fighting electrical storm
Paradoxical progress of function and fibrosis in FLNC cardiomyopathy after therapy
